Cover Image
市場調查報告書

Bioo Therapeutics的產品平台分析

Bioo Therapeutics - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 253713
出版日期 內容資訊 英文 22 Pages
訂單完成後即時交付
價格
Back to Top
Bioo Therapeutics的產品平台分析 Bioo Therapeutics - Product Pipeline Review - 2015
出版日期: 2015年04月22日 內容資訊: 英文 22 Pages
簡介

Bioo Therapeutics是總公司設在美國的生物科技企業,進行癌症等治療藥開發基礎的抗體和小分子、毒素的研究。

本報告提供Bioo Therapeutics 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Bioo Therapeutics 基本資料

  • Bioo Therapeutics 概要
  • 主要資訊
  • 企業資料

Bioo Therapeutics :R&D概要

  • 主要的治療範圍

Bioo Therapeutics :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品

Bioo Therapeutics :開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Bioo Therapeutics:藥物簡介

  • BIOO-1
  • BIOO-2
  • BIOO-3
  • BIOO-4
  • BIOO-5
  • BIOO-6
  • BIOO-7

Bioo Therapeutics :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06969CDB

Summary

Global Markets Direct's, 'Bioo Therapeutics - Product Pipeline Review - 2015', provides an overview of the Bioo Therapeutics's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bioo Therapeutics's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Bioo Therapeutics including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Bioo Therapeutics's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Bioo Therapeutics's pipeline products

Reasons to buy

  • Evaluate Bioo Therapeutics's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Bioo Therapeutics in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Bioo Therapeutics's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Bioo Therapeutics and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bioo Therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Bioo Therapeutics and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Bioo Therapeutics Snapshot
    • Bioo Therapeutics Overview
    • Key Information
    • Key Facts
  • Bioo Therapeutics - Research and Development Overview
    • Key Therapeutic Areas
  • Bioo Therapeutics - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Bioo Therapeutics - Pipeline Products Glance
    • Bioo Therapeutics - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Bioo Therapeutics - Drug Profiles
    • BIOO-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BIOO-2
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BIOO-3
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BIOO-4
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BIOO-5
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BIOO-6
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BIOO-7
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Bioo Therapeutics - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Bioo Therapeutics, Key Information
  • Bioo Therapeutics, Key Facts
  • Bioo Therapeutics - Pipeline by Indication, 2015
  • Bioo Therapeutics - Pipeline by Stage of Development, 2015
  • Bioo Therapeutics - Monotherapy Products in Pipeline, 2015
  • Bioo Therapeutics - Partnered Products in Pipeline, 2015
  • Bioo Therapeutics - Partnered Products/ Combination Treatment Modalities, 2015
  • Bioo Therapeutics - Preclinical, 2015
  • Bioo Therapeutics - Discovery, 2015

List of Figures

  • Bioo Therapeutics - Pipeline by Top 10 Indication, 2015
  • Bioo Therapeutics - Pipeline by Stage of Development, 2015
  • Bioo Therapeutics - Monotherapy Products in Pipeline, 2015
Back to Top